Lifetime Outcomes of Anti–Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration

IMPORTANCE: Neovascular age-related macular degeneration (nAMD), the largest single cause of irreversible severe vision loss in high-income countries, can now be treated with vascular endothelial growth factor (VEGF) inhibitors, but to our knowledge, no data on lifetime outcomes are available. OBJEC...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:JAMA Ophthalmol
Hlavní autoři: Finger, Robert P., Puth, Marie-Therese, Schmid, Matthias, Barthelmes, Daniel, Guymer, Robyn H., Gillies, Mark
Médium: Artigo
Jazyk:Inglês
Vydáno: American Medical Association 2020
Témata:
Original Investigation
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7563682/
https://ncbi.nlm.nih.gov/pubmed/33057589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaophthalmol.2020.3989
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky